Information:
Fel:
Nyckelord
ALL ×
- Clinical Trial (30)
- Pediatrics (25)
- Therapeutics (17)
- Antineoplastic Protocols (10)
- Eligibility Determination (4)
- Hematology (3)
- Laboratories (2)
- Medical History Taking (2)
- Recurrence (1)
- Registries (1)
- Asparaginase (1)
- Hematopoietic Stem Cell Transplantation (1)
- Central Nervous System Diseases (1)
- Maintenance Chemotherapy (1)
- Adverse event (1)
- Drug trial (1)
- Cytarabine (1)
- Diet (1)
- Pentoxifylline (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
32 Sökresultat.
Item-grupper: Criteria, Inclusion Criteria, Exclusion Criteria
Item-grupper: Patient Information, Therapy, Severe adverse event, Identification and Signature
Item-grupper: Patient Information, Laboratory Parameters Study Section, Laboratory Parameters Control Section, Identification and Signature
Item-grupper: Patient Information, Laboratory Parameters Study Section, Laboratory Parameters Control Section, Identification and Signature
Item-grupper: Patient Information, Chemotherapy Regimen, Identification and Signature
Item-grupper: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
Item-grupper: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
Item-grupper: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
Item-grupper: Patient Information, Therapy, Blood analysis, Toxicity, Comments, Identification and Signature
Item-grupper: Patient Information, Examinations, Identification and Signature
Item-grupper: Patient Information, First Element, Second Element, Third Element, Fourth Element, Fifth Element, Sixth Element, Seventh Element, Eighth Element, Ninth Element, Cranial radiation, Maintenance treatment, Comments, Identification and Signature
Item-grupper: Patient Information, Anamnesis, Diagnosis, Blood analysis, Initial CNS status, Multi-organ involvement, Prednisone response, Comments, Identification and Signature